The rapid adoption of electronic medical records and electronic health records by companies across the world drives the global revenue cycle management market or RCM market. Fortune Business Insights in its new report, titled “Revenue Cycle Management: Global Market Analysis, Insights and Forecast 2018-2025” predicts the market to grow at a remarkable rate during the forecast period. North America is expected to contribute significantly towards the growth of the revenue cycle management market.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/revenue-cycle-management-market-100275

The rising adoption of RCM among end users and presence of well-established healthcare infrastructure is expected to drive the RCM market in North America. In addition to this, revenue cycle management solutions offer long-term benefits, which is a key reason behind its high uptake in the region. Furthermore, the increasing presence of physicians and hospitals in North America will fuel the demand for revenue cycle management services in the coming years.

According to studies, Asia Pacific is projected to exhibit a high growth in the global RCM market. The growth is primarily attributable to the rising target population looking for medical claims and treatment. Moreover, the market is expected to witness exceptional growth opportunities in India, China, Singapore, and Japan.

Advent of IT and Analytics in Healthcare Industry Boosts the Market 

“Cloud-based solutions are in high demand across the world for seamless data sharing,” stated a lead analyst at Fortune Business Insights. “Several companies are increasingly adopting cloud-based platforms to offer advanced revenue cycle management services,” he added. Robust government initiatives, coupled with decrease in healthcare reimbursements, are likely to drive the RCM market in the coming years. The rising use of analytical tools and IT in the healthcare industry is expected to increase the revenue generated by the RCM market between 2018 and 2025.

As per a survey conducted by a research organization called Black Book, out of 500 U.S. hospitals surveyed, 400 hospitals implemented revenue cycle managements systems. With the help of analytical tools, RCM services provide better remote assistance and reduce vendor fees. They also help in streamlining the robotic process automation, encouraging companies to adopt RCM technologies.

The increasing prevalence of respiratory diseases and alpha-1 antitrypsin deficiency among people worldwide is boosting the global plasma fractionation market, says Fortune Business Insights in a new study. The report, titled “Plasma Fractionation: Global Market Analysis, Insights, and Forecasts 2018 to 2026,” offers insights into growth drivers and restraints impacting the plasma fractionation market.

Browse Complete Report:

https://www.fortunebusinessinsights.com/industry-reports/plasma-fractionation-market-101614

Rise in Number of Diagnostic Centers for using Plasma Proteins as Therapeutics to Bode Well for Market

The rising awareness about diseases because of the expansion of media and increasing number of diagnostic centers have increased the value of plasma fractionation. This is a major factor boosting the overall market. In addition to that, increasing investments made in designing of therapeutics for chronic diseases is also anticipated to drive the global market. Besides this, the increasing popularity and usage of proteins derived from plasma for various treatments is presumed to bode well for the global market.

However, high cost of fractionation and insufficient reimbursement policies may cause hindrance to the growth of the market. This, accompanied by the emergence of recombinant alternatives may hamper the market in the long run.

North America Emerges Dominant on Account of Better Healthcare Infrastructures

Geographically, the global market for plasma fractionation is dominated by North America at present. Factors promoting growth in this region are better healthcare infrastructures, government supported reimbursement policies, and presence of large company in developed nations of the region namely Canada and the U.S. Moreover, recent approvals from the Food and Drug (FDA) favor the growth of new plasma fractionation facilities are thus creating lucrative growth opportunities for the market in North America. For instance, the FDA approved a plasma fractionation facility in Melville for Kedrion S.P.A. in February 2019.

The plasma fractionation market in Asia Pacific is also anticipated to show huge growth potentials on account of developing healthcare infrastructure and research centers, and the increasing investments for drug discoveries.

The global contraceptive pills market size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period. High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market. Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed that around 8% to 38% of married rural women, aged between 15 and 49 years, faced unmet contraceptive needs.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-pills-market-101802

The main reason for this gap is the lack of accessibility and local availability of birth-control pills in these areas. To counter this, governments in many developing and underdeveloped countries are taking efforts to make these modern day medications more accessible and affordable to the rural populace. This will effectively accelerate the oral contraceptives market growth during the forecast period.

Fortune Business Insights™, in its report, titled “Contraceptive Pills Market Size, Share & Industry Analysis, By Type (Combination Pills and Progestin-only Pills), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGO, and Others) and Regional Forecast, 2019-2026”, states that the value of this market stood at USD 13.11 billion in 2018. In addition to this information, the report shares the following insights:

• A microscopic analysis of the major factors and drivers shaping the market;
• A meticulous research into the most defining regional and competitive dynamics characterizing this market;
• An in-depth profiling of the key players operating in this market; and
• A holistic study of the different market segments.

Expeditious Need to Curb Population Growth to Feed Market Development

According to the United Nations’ Department of Economic and Social Affairs, by 2030, world population will reach 8.6 billion and by 2050, it will be 9.8 billion. The prevalent anxiety is that such explosion of numbers will create wide socio-economic imbalances, especially in poor countries. Proactive measures are being taken by governments across the globe about family planning and use of the contraceptives to avoid unnecessary pregnancies. This desperate need to control population growth is expected to be one of the leading contraceptive pills market trends in the immediate future. Furthermore, increasing prevalence of teenage pregnancies, particularly in the U.S. has also emerged as a central factor driving the growth of this market.

The global microfluidic devices market is expected to gain impetus from increasing technological advancements in the biotechnology domain. According to a report by Fortune Business Insights, titled, “Microfluidic Devices Market Size, Share & Industry Analysis, By Device Type (Chips, Sensors, and Others), By Material (Glass, Silicon, PDMS and Others), By Applications (Pharmaceutical & Life Science Research, Diagnosis & Treatment, and Others), By End-user (Diagnostic Centers, Research Institutes, Pharmaceutical and Biotechnology Companies, Healthcare Facilities and Others) and Regional Forecast, 2019-2026,” the market is projected to reach USD 22.65 Billion by 2026, thereby exhibiting a CAGR of 20.5% during the forecast period. However, the global microfluidic devices market size was valued at USD 5.14 Billion in 2018. The report further states that renowned market players are focusing on low-cost materials for manufacturing microfluidic sensors and chips. It would contribute to the market growth in the forthcoming years.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/microfluidic-devices-market-101098

Fortune Business Insights profiles some of the renowned companies operating in the global microfluidic devices market. They are as follows:

• uFluidix
• Perkin Elmer
• Fluidigm
• Blacktrace Holdings Ltd. (Dolomite Microfluidic)
• Micronit
• BioFluidix GmbH‎
• Fluigent
• ALine, Inc.
• Philips
• Other prominent players

Highlights of the Report

• In-depth analysis of various insights, namely, Microfluidic Devices Market trends, growth drivers, opportunities, and other related challenges.
• Comprehensive details of key market players, their core competencies, and market shares.
• The potency of suppliers and buyers to make better business decisions.
• Lists out the market size in terms of volume.

Rising Usage of Microfluidic Devices to Boost Growth of Pharmaceutical and Biotechnology Companies Segment

In terms of end-user, the global microfluidic devices market is grouped into pharmaceutical and biotechnology companies, research institutes, diagnostic centers, and healthcare facilities and others. Out of these, the pharmaceutical and biotechnology companies segment is projected to lead the global market by acquiring the highest revenue in terms of share. It would occur due to the increasing manufacturing and usage of sensors, chips, and other microfluidic devices to offer novel and robust devices to the consumers. However, diagnostic centers and research institutes will also grow rapidly during the forecast period by utilizing microfluidic devices for various applications.

The Global Mass Spectrometer Market is likely to expand at a CAGR of 7.8% between 2019 and 2026. Fortune Business Insights in a report, titled “MASS SPECTROMETER: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2019-2026” predicts that the adoption of mass spectrometer equipment is likely to increase as this equipment can precisely measure the molecular weight of an analyst. The mass spectrometer instrument together with chromatography calculates the analytical mass of a particular molecule. The report predicts the Global Mass Spectrometer Market was valued at US$ 5,512.2 Mn in the year 2018 and is anticipated to reach US$ 10,044.7 Mn by 2026.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/mass-spectrometer-market-101068

Market in North America Continues to Lead Owing to Presence of Key Players in the U.S.

Among regions, the market in North America is expected to maintain its dominance through the forecast period. Moreover, the regional market was valued at US$ 2,126.7 Mn in the year 2018. Presence of recognized key players and technological advancements are creating lucrative opportunities for the market. Governments in this region are granting funds to research institutes working on in mass spectrometry, which will further increase the mass spectrometer market share in North America. The University of Georgia recently received grants from the National Institutes of Health in the U.S. This funding is for conducting biomedical research and this is another factor responsible for the high growth of the market in this region.

A report by the Industrial Research Institute (IRI) finds that the U.S. is the only country in the world who spends aggressively on research and development activities. Governments in North America are increasingly investing in areas such as biomedical, biotechnology, and proteomics. Such factors are likely to accelerate the mass spectrometer market size in North America. 

The global animal health market size is anticipated to reach USD 67.56 billion by 2026 owing to the increasing number of animal health issues worldwide. Animals have always been of immense help to man either as companions or as livestock. With time, man starting adopting animals and keeping them as pets. Animals, alike humans, are susceptible to infections and diseases and require medical aid. As per a recently published report by Fortune Business insights™ titled, “Animal Health Market Size, Share and Global Trend By Product (Drugs, Vaccines, Feed, and Diagnostics), By Animal (Livestock Animals and Companion Animals), By End User (Veterinary Hospitals & Clinics, Animal Care & Rehabilitation Centers, Diagnostic Centers, and Others) and Geography Forecast till 2026” the market size was USD 41.50 billion in 2018 and is anticipated to rise at a CAGR of 6.3%.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/animal-health-market-102371

Major Animal Health Companies in Market are as follows:

• Emergent BioSolutions, Inc.
• Boehringer Ingelheim International GmbH
• Novartis AG
• Virbac
• Intervet Inc.
• Bayer AG
• Zoetis
• Ceva

Objectives of the Report

The report on the veterinary healthcare market is based on qualitative and quantitative analysis of factors driving, repelling, and challenging the market. It also provides a well-presented segmentation of the market based on factors such as product, animal, end user, and region. Additionally, the report offers insights about key industry developments and recent innovations in the market with the list of market names and the blueprints chalked out by them to stay ahead of the market competition. Furthermore, the report lists the current animal healthcare market trends and opportunities and is available for sale on the company website.

Presence of Advanced Teams for Research and Development Activities Will Aid Growth of the Market in North America

Geographically, the global animal health market is categorized into Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. These regions are further categorized into nations. Among these, North America held the largest veterinary healthcare market share and generated a revenue of USD 14.12 billion in 2018. This is attributable to the presence of numerous animal health centers and technologically advanced team for research and development of novel therapeutics. Besides this, the rise in the number of pet owners and their rising concern for maintaining the health of their pets will help in the expansion of the market.

The global orthopedic devices market is set to gain traction from the ever-increasing geriatric population across the world. As per a research published in 2015 by the United Health Foundation, every year, more than 300,000 adults belonging to the age group of 65 years and above are estimated to be hospitalized for hip fractures. Besides, around 30% of seniors fall per year. It is further leading to higher number of orthopedic injuries.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/orthopedic-devices-market-102586

Fortune Business Insights™ published this information in a recent study, titled, “Orthopedic Devices Market Size, Share & Industry Analysis, By Type (Joint Reconstruction Devices, Spinal Devices, Trauma Devices, Dental Implants, Orthobiologic Devices, Arthroscopy Devices, and Others), By End User (Hospitals, Orthopedic Clinic, Ambulatory Surgical Centers, and Others), and Regional Forecast, 2019-2026.” The study further mentions that the orthopedic devices market size stood at USD 51.33 billion in 2018 and is projected to reach USD 71.67 billion by 2026, thereby exhibiting a CAGR of 4.3% during the forecast period.

Fortune Business Insights™ presents a list of all the companies operating in the orthopedic medical devices market. They are as follows:

• Smith & Nephew
• Stryker
• Zimmer Biomet
• Medical Devices Business Services, Inc. (Johnson & Johnson)
• NuVasive, Inc.
• Medtronic
• Integra LifeSciences

High Purchasing Power of the Masses to Favor Growth in Asia Pacific

Geographically, the market is fragmented into Latin America, Asia Pacific, the Middle East and Africa, North America, and Europe. Amongst these, North America procured USD 23.86 billion orthopedic medical devices market revenue in 2018. This growth is attributable to the presence of adequate reimbursement policies, as well as surging incidence of orthopedic surgeries. Apart from these, availability of state-of-the-art treatment options and rising awareness among the patient pool regarding the presence of these advanced devices would contribute to the market growth.

Joint Reconstruction Segment to Lead Backed by Increasing Number of Surgical Procedures

Based on type, the market is grouped into joint reconstruction devices, dental implants, trauma devices, spinal devices, orthobiologic devices, arthroscopy devices, trauma devices, and others. Out of these, in 2018, the joint reconstruction segment held 35.8% in terms of orthopedic devices market share and is anticipated to lead the market throughout the forecast period. This growth is attributable to the rising number of procedures, namely, extrementies and shoulder reconstructions, hip and knee replacements, and other similar procedures associated with joints

The global thin film drugs market size is projected to reach USD 16.27 billion in 2028. Fortune Business Insights™ published this information in a new study, titled, “Thin Film Drugs Market, 2021-2028.” The study further mentions that the market stood at USD 7.35 billion in 2020. It is expected to showcase a CAGR of 10.5% in the forecast period between 2021-2028. The surging geriatric population across the globe is anticipated to affect growth positively. As per the United Nations, in 2017, the global old age population was 962 million. It is estimated to double by the end of 2050 and reach 2.1 billion. Hence, the prevalence of Alzheimer’s and Parkinson’s diseases will also increase rapidly, thereby accelerating the demand for thin film drugs.

please visit: https://www.fortunebusinessinsights.com/thin-film-drugs-market-104883

Rising Focus on Developing COVID-19 Vaccine to Impact Growth Negatively

Several pharmaceutical companies are currently focusing on inventing a vaccine that would fight against the COVID-19 pandemic. It has resulted in disruptions of research and development activities associated with thin film drugs in various parts of the world. It is expected to hamper growth of the market in the near future. Our research reports will help you find the best strategy to uplift your businesses amid this pandemic.

Government Initiatives to Innovate Drug Delivery Models will Boost Growth in Europe

• North America: The region generated USD 2.66 billion in terms of revenue in 2020. It is expected to grow significantly fueled by the increasing prevalence of neurological disorders, such as Alzheimer’s and Parkinson’s disease in the U.S. As per the Alzheimer’s Association, in 2020, 5.8 million Americans belonging to the age group of 65 years and older were living with Alzheimer’s dementia. Also, the rising cases of schizophrenia in the region would also propel growth.
• Europe: The increasing research and development activities in the region to create thin film drugs would aid growth. Coupled with this, the surging government initiatives and fundings to innovate various drug delivery models would accelerate growth.
• Asia Pacific: The region is likely to showcase stable growth because of the rising spending on healthcare infrastructure and increasing old age population. Also, the surging awareness about the benefits of adopting these drugs would bolster regional growth.

The Dental Crowns and Bridges Market is likely to gain momentum from the rising usage of digital dentistry. Presently, masses at are choosing various digital equipment, such as milling machines, computer software, scanners, and radiological devices for restorative and preventive dentistry. Teeth structures are also being customized by using CAD/CAM, as well as 3D printing technologies.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/dental-crowns-and-bridges-market-102714

This information is published by Fortune Business Insights™ in a recent report, titled, “Dental Crowns and Bridges Market Size, Share & Industry Analysis, By Type (Crowns, and Bridges), By Material (Ceramics, Porcelain Fused to Ceramics, and Metals), By End User (Dental Hospitals & Clinics, Dental Laboratories, and Others), and Regional Forecast, 2019-2026.” The report further mentions that the Dental Crowns and Bridges Market size was USD 2.85 billion in 2018 and is projected to reach USD 4.56 billion by 2026, exhibiting a CAGR of 6.1% during the forecast period.

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

Ability to Provide Lucent Finish will Drive Growth of the Ceramics Segment

Based on material, the market is grouped into metals, porcelain fused to metals, and ceramics. Out of these, the ceramics segment held 55.2%Dental Crowns and Bridges Market share in 2018 and is anticipated to remain dominant throughout the forecast period. This growth is attributable to the ability of ceramics to provide an attractive lucent finish to bridges and crowns. Also, they possess a similar aesthetic appearance to the original tooth. They are also strong and tough in nature and therefore, can be customized as per the patient’s requirement.

Rising Geriatric Population to Favor Growth in Europe

Geographically, the market is divided into the Middle East and Africa, Europe, Latin America, North America, and Asia Pacific. Amongst these, Europe procured USD 1.16 billion Dental Crowns and Bridges Market revenue in 2018. This growth is attributable to the higher adoption of digital dentistry equipment, surging dental expenditures, and rising geriatric population. Also, increasing and treatment and diagnosis rate for various dental disorders would propel growth of the market in this region.

The Global Nurse Call Systems Market is anticipated to showcase notable growth owing to the reduction in the number of patient to nurse ratio. According to a report by Fortune Business Insights, titled, “Nurse Call Systems Market Size, Share & Industry Analysis, By Technology (Wired, Wireless), By Product (Basic Button Based Systems, Mobile Integrated Systems, IP Based Systems, Others), By End-user (Hospitals and Clinics, Assisted Living and Nursing Centres, Home Care Setting, Others), and Regional Forecast, 2019-2026,” the global nurse call systems market size was valued at USD 1.18 Billion in 2018. However, the global market is projected to reach USD 2.78 Billion by 2026, exhibiting a CAGR of 11.4% during the forecast period.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/nurse-call-systems-market-100274

Increasing Incidence of Chronic Disorders to Aid in the Growth of Hospital Segment

In terms of end user, the global nurse call systems market is grouped into home care settings, assisted living and nursing centers, hospitals and clinics, and others. The report mentions that hospitals are expected to generate the highest global nurse call systems market revenue in the forthcoming years. It would occur as the nurses in hospitals depend upon nurse call systems for workforce management, emergency management, and monitoring of patients’ health. Also, hospitals possess high patient pool who are in persistent need for general healthcare. Additionally, the rising prevalence of chronic diseases are leading to hospitalizations. It will contribute to the global nurse call systems market growth in the coming years.

Ascom and Rauland-Borg Launch Advanced Nurse Call Systems to Increase Efficiency

Ascom, a global solutions provider, headquartered in Switzerland, announced the launch of its Telligence in North America in February 2019. Telligence is considered to be the world’s first patient response system. It is a scalable and modular patient response system that upgrades nurse call service for unique patient-centric care. With the guidance of Telligence, caregivers can get access to appropriate information throughout the care process as well as at the point of care.

It is developed on the Ascom Healthcare Platform and it aids in collecting information from several sources, such as healthcare applications, patients, applications, and other medical devices. It has the ability to smoothly integrate with the facility’s current applications and devices. Doctors and clinicians can get an in-depth view of the patient’s health status that is much better than the traditional form of nurse call. It helps the caregivers to get to know about the patient’s current health condition and response to their requests accordingly.